Letter: Cohort Study Examining the Association Between Proton Pump Inhibitor Therapy and Risk of Hepatocellular Carcinoma in Taiwan

Alimentary Pharmacology and Therapeutics - United Kingdom
doi 10.1111/apt.14905
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Letter: Cohort Study Examining the Association Between Proton Pump Inhibitors Therapy and Risk of Hepatocellular Carcinoma in Taiwan-Authors’ Reply

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2018English

Letter: Proton Pump Inhibitors and the Risk of Hepatocellular Carcinoma

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2018English

Letter: Association Between Proton Pump Inhibitor Use and Fracture Risk - Causality or Confounding?

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2018English

Letter: Proton Pump Inhibitor Use and Risk of Fracture

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2018English

Association Between Proton Pump Inhibitor Use and Risk of Progression of Chronic Kidney Disease

Gastroenterology
HepatologyGastroenterology
2017English

PCN8 the Association Between Androgen-Deprivation Therapy in Prostate Cancer and Cardiovascular Risk in Taiwan: A Population-Based Cohort Study

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2012English

Association Between Aspirin Use and Risk of Hepatocellular Carcinoma

JAMA Oncology
Cancer ResearchOncology
2018English

Exam 2: Association Between Proton Pump Inhibitor Use and Cognitive Function in Women

Gastroenterology
HepatologyGastroenterology
2017English

Proton Pump Inhibitor Use and Dementia Risk: Prospective Population-Based Study

Journal of the American Geriatrics Society
GerontologyGeriatrics
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy